Fmoc-L-Arg(Pbf)-OH CAS 154445-77-9 Product Guide
Table of Contents
1. Product Specifications & Comparative Analysis
2. Functional Applications & Usage Scenarios
3. Operational Case Studies
4. Industry Adoption & Client Implementations
5. Procurement Guidance & Technical Consultation
1. Product Specifications & Comparative Analysis
| Parameter | Fmoc-L-Arg(Pbf)-OH | Standard Fmoc-AA |
|---|---|---|
| CAS Number | 154445-77-9 | Varies |
| Molecular Formula | C34H46N4O7S | Dependent on AA |
| Purity Grade | ≥98% (HPLC) | 95-98% |
| Side Chain Protection | Pbf Group | Standard Groups |
2. Functional Applications & Usage Scenarios
Peptide Synthesis Applications:
– Solid-phase peptide synthesis (SPPS) backbone
– Critical component in GPCR-targeting peptides
– HIV protease inhibitor development
– Vaccine adjuvant peptide sequences
Pharmaceutical Research:
– Controlled drug delivery systems
– Antibody-drug conjugate (ADC) linkers
– Tumor-targeting peptide frameworks
3. Operational Case Studies
Case 1: Anticoagulant Peptide Development
Research team optimized thrombin inhibition rates by 38% through strategic Pbf-protected arginine positioning in heparin-binding domains.
Case 2: Antimicrobial Peptide Production
Manufacturing yield increased from 67% to 89% by implementing temperature-controlled Fmoc removal cycles during SPPS processes.
4. Industry Adoption & Client Implementations
Client A: PeptideTech Inc. (USA)
– Application: VIP receptor agonists
– Implementation: 15kg batch production
– Outcome: 92% purity achieved with 0.3% diastereomer content
Client B: BioSynth Laboratories (EU)
– Application: COVID-19 spike protein analogs
– Implementation: Continuous flow synthesis adaptation
– Outcome: 40% reduction in solvent consumption
5. Procurement Guidance & Technical Consultation
Bulk Order Specifications:
– MOQ: 100g (GMP grade)
– Lead Time: 3-5 weeks
– Stability: 24 months @ -20°C
Contact our peptide experts:
✉️ info@vivalr.com
(86) 15866781826
Request batch-specific COA or MSDS documentation:
Click for Technical Documents



评论
目前还没有评论。